Posted inStartup
Accipiter Biosciences Secures Additional $10.5M to Accelerate AI Drug Discovery Programs
Seattle-based biotechnology startup Accipiter Biosciences has secured an additional $10.5 million in seed funding to accelerate its artificial intelligence-driven drug development pipeline. The capital injection allows the company to move…
